Your target's healthcare costs hide $2-4M in phantom spread. Post-close teams can't find it. Buyers discount your exit claims. Evidence-backed diligence changes everything.
Traditional diligence misses hidden healthcare spreads, creating post-close surprises that evaporate EBITDA and crater exit multiples
From data upload to management presentation in under 2 days. Evidence-backed findings, normalized EBITDA model, and post-close playbook included.
Secure upload of pharmacy claims, PBM contract, census, and plan design documents into isolated diligence workspace
AI-driven analysis surfaces hidden spreads, benchmarks claims against NADAC, identifies contract leakage, and generates risk heat maps
SiriusB iQ team validates findings, builds normalized EBITDA model, and creates board-ready evidence package with recovery scenarios
Live walkthrough with deal team covering findings, value at-risk, quick wins, and post-close governance framework recommendation
Continuous value tracking, governance automation, and exit documentation across your entire portfolio
Portfolio-wide dashboard tracking healthcare costs, realization status, and governance compliance across all holdings with real-time alerts
Owner-assigned synergy tracking with weekly reconciliation workflows, evidence receipt generation, and automated variance alerting
Continuous monitoring of PBM contract performance vs. guarantees with automated breach detection and recovery workflow initiation
Real-time comparison of pharmacy costs against NADAC, peer portfolios, and Mark Cuban Cost Plus pricing with immediate outlier flagging
AI-powered analysis surfaces immediate value opportunities with pre-built evidence packs and implementation playbooks for rapid deployment
Automated creation of buyer-ready evidence packages documenting all value creation with audit-grade receipts and governance framework handoff